Aarthi Jayanthan

Polo-Like Kinase 1 Inhibition Kills Glioblastoma Multiforme Brain Tumor Cells in Part Through Loss of SOX2 and Delays Tumor Progression in Mice

Cathy Lee, Abbas Fotovati, Joanna Triscott et al. · Stem Cells · 2012 · 74 citations · Full text

Cell Death, Pathology, High-grade Gliomas +19

Profiling pathway‐specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR‐ ErbB2 signaling with lapatinib

Anjali Singh, Xueqing Lun, Aarthi Jayanthan et al. · Molecular Oncology · 2013 · 41 citations · Full text

Cns Atrt, Drug Target, Chemoprevention Strategy +25

Curcumin Blocks Kv11.1 (<i>erg</i>) Potassium Current and Slows Proliferation in the Infant Acute Monocytic Leukemia Cell line THP-1

Umberto Banderali, Darrell D. Belke, Anjali Singh et al. · Cellular Physiology and Biochemistry · 2011 · 30 citations · Full text

Cellular Physiology, Kv11.1 Activity, Tumor Biology +18

Effects of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) on Pediatric Acute Lymphoblastic Leukemia (ALL) with Respect to Bcr-Abl Status and Imatinib Mesylate Sensitivity

Lindsay Hawkins, Aarthi Jayanthan, Aru Narendran · Pediatric Research · 2005 · 29 citations · Full text

Imatinib Mesylate Sensitivity, Hematological Malignancy, Oncology +9

Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition

Anjali Singh, Aarthi Jayanthan, Allyson Farran et al. · Leukemia Research · 2011 · 28 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +11